Financhill
Back

Akari Therapeutics PLC Vs. DBV Technologies SA Industry Stock Comparison

Sell
46

AKTX
Akari Therapeutics PLC

Last Price:
2.44
Seasonality Move:
-8%
Sell
37

DBVT
DBV Technologies SA

Last Price:
0.68
Seasonality Move:
3.6%
Sell
46
Akari Therapeutics PLC (AKTX) is a Sell

Is Akari Therapeutics PLC a Buy, Sell or Hold?

  • The current Akari Therapeutics PLC [AKTX] share price is $2.45. The Score for AKTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • AKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
DBV Technologies SA (DBVT) is a Sell

Is DBV Technologies SA a Buy, Sell or Hold?

  • The current DBV Technologies SA [DBVT] share price is $0.68. The Score for DBVT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • DBVT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKTX Stock Price Chart

What is Akari Therapeutics PLC's stock price today?

  • The Akari Therapeutics PLC share price today is $2.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing slight buying pressure.

DBVT Stock Price Chart

What is DBV Technologies SA's stock price today?

  • The DBV Technologies SA share price today is $0.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DBVT is experiencing selling pressure, which indicates risk of future bearish movement.

AKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 45.84 Sell
Chaikin Money Flow: 4146 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.25 - 2.79) Sell
Bollinger Bands (100): (2.67 - 3.71) Sell

DBVT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 40.05 Sell
Chaikin Money Flow: -85957 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.69 - 0.79) Sell
Bollinger Bands (100): (0.72 - 0.92) Sell

AKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.46 Sell
20-day SMA: 2.42 Buy
50-day SMA: 2.89 Sell
200-day SMA: 2.57 Sell
8-day EMA: 2.43 Buy
20-day EMA: 2.51 Sell
50-day EMA: 2.77 Sell
200-day EMA: 3.02 Sell

DBVT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.76 Sell
20-day SMA: 0.75 Sell
50-day SMA: 0.74 Sell
200-day SMA: 1.14 Sell
8-day EMA: 0.75 Sell
20-day EMA: 0.75 Sell
50-day EMA: 0.77 Sell
200-day EMA: 1.17 Sell

Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.

DBV Technologies SA Earnings Growth & DBVT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.19 per share.

Akari Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

DBV Technologies SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):